Unknown PHASE3 INTERVENTIONAL 2-arm NCT01050595

Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit (MOVE-IT)

Methylnaltrexone for the Reversal of Opiate-Induced Constipation in the Intensive Care Unit

Sponsor: St. John Health System, Michigan

Interventions Methylnaltrexone Bromide Placebo-Normal Saline

Updated 5 times since 2017 Last updated: Jan 13, 2010 Started: Dec 31, 2009 Primary completion: Oct 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Opioid-induced Constipation, this trial is ongoing. The trial is conducted by St. John Health System, Michigan and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Feb 2017 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE3

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

St. John Health System, Michigan

Data source: St. John Health System, Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Southfield, United States